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Cardiopulmonary Exercise Testing and Cardiopulmonary Morbidity in Patients 
Undergoing Major Head and Neck Surgery 
 
Abstract 
Cardiopulmonary exercise testing (CPET) is used as a risk stratification tool for 
patients undergoing major surgery. In this study, we investigated the role of CPET in 
predicting day five cardiopulmonary morbidity in patients undergoing head and neck 
surgery.  
This observational cohort study included 230 adults undergoing major head and neck 
surgery. We recorded preoperative CPET variables and day five postoperative 
cardiopulmonary morbidity. 
Full data from 187 patients were analysed; 43 patients either had incomplete data sets 
or declined surgery/CPET. One hundred and nineteen patients (63.6%) developed 
cardiopulmonary morbidity at day five. Increased preoperative heart rate and duration 
of surgery were independently associated with day five cardiopulmonary morbidity. 
Those with such morbidity also had lower peak VȮ2 11.4(IQR 8.4-18.0) vs 16.0(IQR 
14.0-19.7)ml.kg-1.min-1, P<0.0001 and V̇O2 at AT 10.6(IQR 9.1-13.1) vs 11.5(IQR 
10.5-13.0)ml.kg-1.min-1, P=0.03. Logistic regression model containing peak V̇O2 and 
duration of surgery demonstrated that increased peak V̇O2 was associated with a 
reduction in the likelihood of cardiopulmonary complications OR 0.92(95%CI 0.87-
0.96), P=0.001. The area under the receiver operating characteristic curve for this 
model was 0.75(95%CI 0.68-0.82), P<0.0001, 64% sensitivity, 81% specificity. 
CPET can help to predict day five cardiopulmonary morbidity in the patients 
undergoing head and neck surgery. A model containing peak V̇O2 allowed 
identification of those with such complications 
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Introduction 
Postoperative complications are common after major head and neck surgery, with 
published rates varying between 55% and 72%.1-3 In particular, patients undergoing 
such surgery are at high risk of developing cardio-vascular and respiratory 
complications in the early postoperative period.4 Current perioperative pathways seem 
to be unable to consistently predict or reduce postoperative morbidity in patients 
undergoing major head and neck surgery.2 In this study, we evaluated the incidence 
of cardiopulmonary morbidity and high-grade morbidity5 defined by the Postoperative 
Morbidity Survey (POMS)6 and investigated the role of CPET to predict such morbidity.  
CPET is an established part of preoperative assessment and has been used for risk 
stratification in thoracic, abdominal and vascular surgery.7-10 Despite requiring a 
moderate to high level of exertion, CPET is well-tolerated by patients11,12 and is safe 
to conduct on most patient cohorts according to international guidelines.13,14 While 
CPET has proven to be a useful perioperative risk stratification tool for major surgery, 
there are no studies evaluating the role of CPET in perioperative assessment of 
patients undergoing head neck surgery. The aim of this observational study was to 
investigate the ability of CPET variables to predict early cardiopulmonary morbidity in 
patients undergoing major head and neck surgery. 
 
Materials and Methods 
Patients 
The study was undertaken at University College London Hospitals NHS Foundation 
Trust, where participants underwent CPET as part of their routine preoperative 
assessment. There was full compliance with Caldicott Guidelines relating to data 
collection and confidentiality. Ethical approval for collection and analysis of 
postoperative morbidity data were not required as this study was deemed a service 
evaluation by the local research department and by using the NHS Health Research 
Authority decision tool. Adult patients scheduled for major head and neck surgery, with 
or without immediate reconstruction, between September 2011 and December 2017 
were included. Patients with missing morbidity data, inability to perform CPET or who 
did not proceed with surgery were excluded. The patients with intraoperative or early 
postoperative death (prior to the postoperative day five) were included into the 
analysis.  
  
Perioperative Variables 
Patient characteristics including age, gender, body mass index, resting heart rate (HR) 
and the American Society of Anesthesiologists (ASA) physical status score were 
recorded preoperatively. Surgical variables such as length of operation and type of 
surgery also were recorded. Surgical interventions were categorised based on 
modality of reconstruction, i.e. resection followed by immediate reconstruction with 
free or pedicled tissues transfer; resection followed by reconstruction with local tissues 
and/or skin grafts and delayed reconstruction of a pre-existing defect.  
 
Cardiopulmonary Exercise Testing 
CPET was conducted in accordance with the American Thoracic Society and 
American College of Chest Physicians (ATS/ACCP) Guidelines.13 Patients performed 
a symptom-limited ramp test to volitional exhaustion. Incremental cycle ergometry was 
performed using an electro-magnetically braked cycle-ergometer (Lode, Groningen, 
Netherlands) with continuous ECG monitoring (Customed GmbH, Ottobrunn, 
Germany). Patients wore a Cortex face-mask (Hans Rudolph Inc, Kansas City, USA) 
to which a flow/volume turbine was attached. Breath-by-breath gas analysis was 
performed (Cortex Metalyzer 3B, Biophysik, Leipzig, Germany). During exercise, 
arterial blood pressure measurements were taken every two minutes (Orbit-K, 
SunTech Medical, Morrisville, USA) attached to a Cortex Multilyzer (Cortex, Biophysik, 
Leipzig, Germany). 
 
CPET Protocol 
Before testing the equipment was calibrated in accordance to the ATS/ACCP 
Guidelines.13 A suitable ramp was chosen, using a predicted work-rate increment 
equation.15 Exercise testing consisted of a 3-minute rest period after which unloaded 
cycling was performed at a constant cadence of 60rpm for 3 minutes. Thereafter, 
patients performed a symptom-limited incremental ramp test until either volitional 
exhaustion or until the test was terminated by the physiologist. Criteria for test 
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termination were: inability to maintain a constant cadence above 40rpm for 30 
seconds, experience of adverse symptoms (e.g. chest pain) or if the physiological data 
indicated a potential adverse event (e.g. ECG abnormalities).13  
 
CPET Variables 
Throughout CPET oxygen uptake (V̇O2) and carbon dioxide production (V̇CO2) were 
recorded, together with respiratory rate and tidal volume and end-tidal gas tensions 
(PETO2 and PETCO2). Ventilation and gas exchange variables derived from CPET 
included the ventilatory equivalents for oxygen (V̇E/V̇O2) and carbon dioxide 
(VĖ/VĊO2), as well as the oxygen pulse (V̇O2/HR). The anaerobic threshold (AT) was 
determined through a combination of the modified V-slope method (breakpoint in the 
relationship between V̇CO2 and V̇O2)16, changes in ventilatory equivalents and end-
tidal gas tensions.17 Combination of the above methods has been shown to improve 
the precision of AT detection.18 The V̇E/VĊO2 was recorded as the value measured at 
the AT.17 Peak VȮ2 was defined as the highest average VȮ2 over the last 30 seconds 
of ramped exercise.19 Values for peak V̇O2  and AT were adjusted for body mass. 
 
Morbidity  
The primary outcome was POMS-defined cardiopulmonary morbidity at day five using 
cardiac and respiratory domains.6. As a secondary outcome, we recorded high-grade 
POMS morbidity as described by Wong et al.5 for this cohort of patients. Length of 
stay in the intensive care unit (ICU) or high dependency unit (HDU) was recorded 
prospectively for all patients.  
 
Statistical Analysis 
Statistical analysis was performed using SPSS 25 (IBM Corp, NY, USA) and Prism 8 
(GraphPad Software, CA, USA). P<0.05 was taken to be statistically significant. The 
Shapiro-Wilk test was used assess normality of the data with subsequent comparisons 
were made between those who did and did not have cardiopulmonary morbidity on 
day five using parametric (independent sample t-test or Fisher’s exact test) or non-
parametric analyses (Mann-Whitney) where appropriate. Grouped data are reported 
as either Median (interquartile range, IQR) or mean±standard deviation (SD). Receiver 
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operated characteristic (ROC) curves were constructed for peak V̇O2, and V̇O2 at AT 
to evaluate their ability to predict day five cardiopulmonary morbidity. The optimal cut-
off point for these CPET variables to distinguish patients with and without 
cardiopulmonary morbidity were calculated using Youden’s J-index20. Multivariable 
logistic regression analysis included variables which were found to differ significantly 
in patients with and without cardiopulmonary morbidity. The final model was obtained 
using forward stepwise multivariable logistic regression. A ROC curve was 
constructed for this model to assess its ability to predict postoperative 
cardiopulmonary morbidity. Kaplan-Meir survival curves were constructed, using 
optimal cut-off values for peak V̇O2 and V̇O2 at AT to assess differences in length of 
stay in the ICU/HDU.  
 
Results 
Two hundred and thirty patients undergoing major head and neck surgery with 
immediate or delayed reconstruction were included in this study, of whom four had no 
surgery (due to high risk of intraoperative death and/or personal choice) and 13 were 
not able to perform CPET. Out of the remaining 213 patients, complete perioperative 
morbidity data were available for 187(26 patients had incomplete data sets). Two 
patients died within the first five days after surgery. 
Complete demographic and surgical data, including incidence of cardiopulmonary 
morbidity at day five, is presented in Table 1. Patients were grouped by the absence 
or presence of day five cardiopulmonary morbidity and differed significantly in resting 
HR [72.0(IQR 64.2-84.0) vs 78(70.0-88.0)bpm, P=0.0079] and duration of operation 
[607.5(IQR 473.3-706.0) vs 726(IQR 595.0-837.0)minutes, P <0.0001].  
Ninety-four patients (50.3%) required respiratory support at postoperative day 5. 
Three patients (1.6%) developed new myocardial infarction or ischaemia; one of two 
patients with myocardial infarction died on the 4th postoperative day, despite maximal 
support on ICU. One patient suffered from an extensive haemorrhagic stroke at 
postoperative day one which lead to death. Other high-grade POMS-defined morbidity 
findings are presented in Supplementary Table 1. 
Patients with day 5 postoperative cardiopulmonary morbidity had significantly lower 
peak VȮ2 and V̇O2 at AT (Table 2). Optimal cut-off points for prediction of day five 
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cardiopulmonary morbidity for peak VȮ2 and V̇O2 at AT were calculated at 12.3ml.kg-
1.min-1 and 10.1ml.kg-1.min-1, respectively (Supplementary Table 2). The area under 
the receiver operating characteristic (AUROC) for peak VȮ2 and V̇O2 at AT were 
0.68(95%CI 0.6-0.7), P<0.001 and 0.59(95%CI 0.51-0.67), P=0.03 respectively. 
All cases with day five POMS-defined cardiopulmonary morbidity were dichotomised 
around the optimal cut-off point for V̇O2 at AT, as described previously.21 Significantly 
higher rates of day five POMS-defined pulmonary complications were observed in 
patients with V̇O2 at AT<10.1ml.kg-1.min-1. Forty-five patients (62.5%) required 
respiratory support (P=0.01), while 52(72.2%) patients had increased oxygen 
requirements (P=0.0008) (Supplementary Table 3). Independently, resting HR, ASA, 
duration of operation and peak VȮ2 were associated with day 5 cardiopulmonary 
morbidity (P<0.05). These variables were used for the multivariable regression 
analysis (Table 3). The odds of cardiopulmonary complications were higher in patients 
who underwent longer surgical procedures odds ratio (OR) 1.003(95%CI 1.001-
1.005), P=0.002. In addition, an increase in peak V̇O2 was associated with a reduction 
in odds of such morbidity (OR 0.92(95%CI 0.876-0.972), P=0.003. This model had 
reasonable power in discriminating between patients with and without day five 
cardiopulmonary morbidity (AUROC 0.75(95%CI 0.68-0.82), P<0.0001, 64% 
sensitivity, 81% specificity) (Figure 1). Survival analysis demonstrated that, 
independently of all other variables, patients with peak V̇O2 and V̇O2 at AT below the 
cut-off points had significantly longer stays in the ICU/HDU (P=0.004 and P=0.002), 
as shown in Figure 2-3 and Supplementary Table 4. 
Discussion  
This observational, cohort study is the first to provide evidence supporting the use of 
CPET for objective preoperative risk assessment in patients undergoing major head 
and neck surgery. Interestingly, there were no significant age differences in those with 
or without cardiopulmonary complications, while elevated preoperative HR in this 
group of patients was associated with the incidence of cardiopulmonary morbidity at 
day five after surgery. These findings are in line with the recently published data on 
the association of preoperative HR with postoperative cardiac morbidity.22  
Peak VȮ2 < 12.3ml.kg-1.min-1 and V̇O2 at AT < 10.1ml.kg-1.min-1 were both 
independent predictors of day five cardiopulmonary morbidity in patients undergoing 
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major head and neck surgery. However, these CPET variables had poor predictive 
value on their own. This finding is consistent with the data from other similar studies.21 
The poor predictive value can be explained by complex interactions between patients’ 
premorbid states and the extent of surgical insult. We hereby demonstrated that peak 
V̇O2 can significantly affect the risk of developing postoperative cardiopulmonary 
morbidity. Both single variable and multivariable logistic regression analyses 
demonstrated that patients undergoing longer surgical procedures had a significantly 
higher rate of postoperative cardiopulmonary morbidity. Our findings are consistent 
with data from studies demonstrating that increased operative time is associated with 
higher rates of postoperative complications.1,23,24 The multivariable logistic regression 
analysis demonstrated that peak V̇O2 and duration of surgery were predictors of 
cardiopulmonary morbidity in patients undergoing major head and neck surgery.  
Our study provides new data on objective preoperative fitness assessment in patients 
undergoing major head and neck surgery. While there is no data available for CPET 
variables in patients undergoing surgery involving the upper aero-digestive tract, three 
recent systematic reviews investigated the correlation between CPET variables, 
morbidity and mortality in patients undergoing non-cardiopulmonary surgery.7,8,10 The 
review by Moran et al.7 concluded that V̇O2 at AT can be used to predict postoperative 
morbidity and level of postoperative care in patients undergoing intra-abdominal 
surgery (morbidity with V̇O2 at AT of <10.1 ml.kg-1.min-1 and caution in cases where 
V̇O2 at AT <10.1–12ml.kg-1.min-1). Interestingly, Moran et al.7 also recommended peak 
V̇O2 of 15ml.kg-1.min-1 as a predictor of 90-day survival in patients undergoing 
pancreatic surgery. Findings by Forshaw at el.25 in patients undergoing 
oesophagectomy demonstrated a higher rate of cardiopulmonary complications in 
those with low peak V̇O2(19.2±5.1ml.kg-1.min-1), although mean difference in peak V̇O2 
in those patients with and without cardiopulmonary morbidity was considered to be 
equivocal (2.3ml.kg-1.min-1, 95%CI 0.06-4.5ml.kg-1.min-1;P=0.04).10 
Our study is in line with other published data on the relationship between the duration 
of surgery and postoperative cardiopulmonary morbidity for both head and neck 
surgery1,3 and surgery in general.23,24,26 Cannandy et al.1 demonstrated that patients 
who were exposed to extended surgical interventions in the head and neck area had 
a significantly higher rate of postoperative complications, independent of the extent of 
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the surgical intervention. 
Potential weaknesses of this study are its un-blinded nature and single-centre design. 
The un-blinded nature of this study may have contributed to confounding by indication 
and reduced recorded rates of postoperative morbidity as both anaesthetic and 
surgical teams were aware and may have acted upon the CPET results.  
 
Conclusion 
In this study, which is the first to investigate the role of CPET in predicting 
cardiopulmonary morbidity in patients undergoing major head and neck surgery, we 
demonstrated that peak V̇O2 of 12.3ml.kg-1.min-1 could be used as a risk stratification 
threshold to predict cardiopulmonary complications in the postoperative period. As 
postoperative morbidity in head and neck surgery remains high, further studies 
assessing the role of perioperative factors (both CPET and non-CPET derived) are 
crucial in the effort to reduce complication rates in patients undergoing major head 
and neck surgery.  
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Figure 1 Receiver operating curve for the multivariable logistic regression  
 
Figure 2 Kaplan-Meir survival curves for the length of stay in the ICU or HDU 
dichotomised at the optimal cut-off points for V̇O2 at anaerobic 
 threshold (Cum Survival – cumulative survival) 
 
Figure 3 Kaplan-Meir survival curves for the length of stay in the ICU or HDU 
dichotomised at the optimal cut-off points for peak V̇O2. (Cum Survival – cumulative 
survival) 
  
  Overall 
No 
cardiopulmonary 
morbidity at day 5 
Cardiopulmonary 
morbidity at day 5 P Value 
Number (%) 187 68 (36.4) 119 (63.6)  
Age, years 58.2 (13.7) 58.5 (14.0) 58.1 (13.6) 0.81 
Body mass index 
(BMI), 
 kg/m2 
25.2(22.8-28.9) 25.1 (22.0-28.7) 25.7 (23.0-29.2) 0.77 
Resting heart rate, 
bpm 76.0 (67.0-86.0) 72.0 (64.2-84.0) 78.0 (70.0-88.0) 0.0079 
Gender     
Male (%) 117 (63.1) 47 (70.1) 70 (58.3)  
Female (%) 70 (36.9) 20 (29.9) 50 (41.7) 0.12 
ASA     
ASA II (%) 115 (61.5) 49 (75.4) 66 (58.9)  
ASA III (%) 62 (33.1) 16 (24.6) 46 (41.2) 0.03 
Operation time, 
minutes 675.0 (553.0-795.0) 607.5(473.3-706.0) 726.0 (595.0-837.0) <0.0001 
Operation type     
Resection followed 
by 
 reconstruction with 
a free flap (%) 
114 (61.0) 36 (52.9) 78 (65.5)  
Resection followed 
by reconstruction 
with a pedicled flap 
(%) 
21 (11.2) 6(8.8) 15 (12.6)  
Resection and 
reconstruction with 
local tissue only (%) 
39 (20.9) 18 (26.5) 21 (17.6)  
Reconstruction only 
(%) 13 (7.0) 8 (11.8) 5 (4.2) 
 
 
Table 1 Demographic and surgical data presented as median (25th -75th percentile), 
mean (SD) or frequency (%). P values were obtained using Mann-Whitney, 
independent samples t-test or Fisher’s exact tests.  
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 Overall No cardiopulmonary morbidity at day 5 
Cardiopulmonary 
morbidity at day 5 P Value 
Peak V̇O2 
(ml.kg-1.min-1) 
14.7  
(9.2-18.9) 16.0 (14.0-19.7) 11.4 (8.4-18.0) <0.0001 
V̇O2 at anaerobic threshold 
 (ml.kg-1.min-1) 11 (9.7-13) 11.5 (10.5-13.0) 10.6 (9.1-13.1) 0.03 
V̇E/V̇CO2 at anaerobic 
threshold 
31.1 
(27.9-34.8) 31.7(28.8- 35.2) 31.1 (27.6-34.7) 0.34 
 
Table 2 CPET variables presented as median (25th -75th percentile). P values were 
obtained using Mann-Whitney test. 
 
 
 
 
 
 Beta coefficient SE coefficient P value OR 95% CI for OR 
Peak V̇O2 -0.080 0.027 0.003 0.923 (0.876-0.927) 
Operation time 0.003 0.001 0.002 1.003 (1.001-1.005) 
ASA grade 0.726 0.366 0.047 2.067 (1.009-4.233) 
 
Table 3 Probability of developing day five postoperative cardiopulmonary 
complications using multivariable logistic regression (Nagelkerke R square 0.172); 
Beta coefficient, unstandardised beta coefficient; SE, standard error; OR, odds ratio; 
CI, confidence interval. 
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